Sixty Degree Capital — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
Antios Therapeutics develops antiviral therapies for hepatitis B virus (HBV) and other viral diseases, including its Active Site Polymerase Inhibitor Nucleotide (ASPIN) ATI-2173 and a capsid assembly modulator program.
BiotechHealthtechMendham, US
Gregory Mayes(Executive Officer, Director)Douglas Mayers(Executive Officer)inTamra Adams(Executive Officer)inAbel De La Rosa(Director)
BoardIyona Rajkomar(Director)inBenjamin Rovinski(Director)
Co-investorsAisling CapitalAltium CapitalAvego BioScience CapitalPontifax Venture CapitalAmzak HealthDelos Capital+8 more
Clearcover is an insurance company that simplifies auto insurance coverage selection and claims processing through a mobile-first platform, enabling fast claim payouts.
InsurTechChicago, US
Kyle Nakatsuji(Executive Officer, Director)inDerek Brigham(Executive Officer, Promoter)inJennifer Kemp(Executive Officer)Jennifer Crutchfield(Executive Officer)Norman Smagley(Executive Officer)in
BoardCynthia Hardy(Director)
Co-investors500 GlobalAmerican Family VenturesBetter Tomorrow VenturesGeodesic CapitalIA Capital GroupLightbank+6 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.